Table 4 Factors associated with ESBL-producing GNB infections among COVID-19 patients admitted in KNH-IDU
Factors | ESBL producer | cOR(95%CI) | P-value | aOR(95%CI) | P-value | |
|---|---|---|---|---|---|---|
Yes n (%) | No n (%) | |||||
Age (years) | ||||||
≤24 | 2 (6.1) | 3 (18.8) | 3.90 (0.49–30.76) | 0.196 | 13.95 (0.74–23.11) | 0.078 |
25–44 | 9 (27.3) | 3 (18.8) | 0.87 (0.16–4.58) | 0.866 | 2.02 (0.21–19.44) | 0.542 |
45–59 | 9 (27.3) | 5 (31.3) | 1.44 (0.32–6.49) | 0.632 | 3.67 (0.40–33.96) | 0.252 |
≥60 | 13 (39.4) | 5 (31.3) | Ref. | Ref | ||
Gender | ||||||
Male | 23 (69.7) | 3 (18.8) | 9.97 (2.32–42.85) | 0.002 | 3.38 (0.59–19.43) | 0.172 |
Female | 10 (30.3) | 13 (81.3) | Ref. | Ref. | ||
Marital status | ||||||
Single | 7 (21.2) | 6 (37.5) | 0.45 (0.12–1.67) | 0.231 | ||
Married | 26 (78.8) | 10 (62.5) | Ref | |||
Presence of comorbidity | ||||||
Yes | 30 (90.9) | 8 (50.0) | 10.0 (2.15–46.61) | 0.003 | 9.86 (1.30–74.63) | 0.027 |
No | 3 (9.1) | 8 (50) | Ref. | |||
SARS-CoV-2 Vaccination status | ||||||
Yes | 8 (24.2) | 3 (18.8) | 1.39 (0.31–6.13) | 0.483 | ||
No | 25 (75.8) | 13 (81.3) | Ref. | |||
Hospitalization outcome | ||||||
Alive | 27 (81.8) | 11 (68.8) | 2.05 (0.52–8.12) | 0.466 | ||
Died | 6 (18.2) | 5 (31.3) | Ref. | |||
Length of hospital stay (Days) | ||||||
Short stay (0–5) | 9 (27.3) | 2 (12.5) | Ref. | Ref. | ||
Medium stay (6–10) | 17 (51.5) | 8 (50) | 0.26 (0.04–1.70) | 0.159 | 0.39 (0.04–4.02) | 0.425 |
Long stay (> 10) | 7 (21.2) | 6 (37.5) | 0.55 (0.14–2.18) | 0.393 | 0.43 (0.06–2.96) | 0.39 |